TACTILE SYSTEMS TECHNOLOGY I (TCMD) Stock Fundamental Analysis
NASDAQ:TCMD • US87357P1003
27.64 USD
+0.02 (+0.07%)
Last: Feb 12, 2026, 10:41 AM
Overall TCMD gets a fundamental rating of 6 out of 10. We evaluated TCMD against 186 industry peers in the Health Care Equipment & Supplies industry. TCMD has an excellent financial health rating, but there are some minor concerns on its profitability. TCMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make TCMD a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- In the past year TCMD was profitable.
- In the past year TCMD had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: TCMD reported negative net income in multiple years.
- TCMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.01%, TCMD belongs to the top of the industry, outperforming 88.17% of the companies in the same industry.
- TCMD has a better Return On Equity (8.86%) than 82.80% of its industry peers.
- TCMD's Return On Invested Capital of 7.56% is amongst the best of the industry. TCMD outperforms 82.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROIC | 7.56% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TCMD's Profit Margin of 5.83% is fine compared to the rest of the industry. TCMD outperforms 79.03% of its industry peers.
- In the last couple of years the Profit Margin of TCMD has remained more or less at the same level.
- TCMD's Operating Margin of 7.39% is fine compared to the rest of the industry. TCMD outperforms 73.12% of its industry peers.
- TCMD's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 49.88%, TCMD is in line with its industry, outperforming 44.62% of the companies in the same industry.
- TCMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TCMD is destroying value.
- TCMD has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, TCMD has more shares outstanding
- Compared to 1 year ago, TCMD has an improved debt to assets ratio.
2.2 Solvency
- TCMD has an Altman-Z score of 9.03. This indicates that TCMD is financially healthy and has little risk of bankruptcy at the moment.
- TCMD's Altman-Z score of 9.03 is amongst the best of the industry. TCMD outperforms 87.63% of its industry peers.
- There is no outstanding debt for TCMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.03 |
ROIC/WACC0.77
WACC9.81%
2.3 Liquidity
- TCMD has a Current Ratio of 3.61. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of TCMD (3.61) is better than 62.90% of its industry peers.
- TCMD has a Quick Ratio of 3.20. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
- TCMD has a Quick ratio of 3.20. This is in the better half of the industry: TCMD outperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 |
3. Growth
3.1 Past
- TCMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
- The Earnings Per Share has been growing slightly by 4.86% on average over the past years.
- TCMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.28%.
- The Revenue has been growing by 9.11% on average over the past years. This is quite good.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
3.2 Future
- The Earnings Per Share is expected to grow by 20.90% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 8.94% on average over the next years. This is quite good.
EPS Next Y14.93%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 35.90, the valuation of TCMD can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of TCMD indicates a somewhat cheap valuation: TCMD is cheaper than 72.58% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.18, TCMD is valued a bit more expensive.
- A Price/Forward Earnings ratio of 27.10 indicates a quite expensive valuation of TCMD.
- TCMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TCMD is cheaper than 72.58% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.01. TCMD is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.9 | ||
| Fwd PE | 27.1 |
4.2 Price Multiples
- 79.03% of the companies in the same industry are more expensive than TCMD, based on the Enterprise Value to EBITDA ratio.
- 94.62% of the companies in the same industry are more expensive than TCMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.67 | ||
| EV/EBITDA | 17.52 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TCMD does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of TCMD may justify a higher PE ratio.
- TCMD's earnings are expected to grow with 20.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.4
PEG (5Y)7.38
EPS Next 2Y19.86%
EPS Next 3Y20.9%
5. Dividend
5.1 Amount
- No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:TCMD (2/12/2026, 10:41:54 AM)
27.64
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners99.01%
Inst Owner Change-2.56%
Ins Owners2.66%
Ins Owner Change-0.31%
Market Cap617.48M
Revenue(TTM)311.51M
Net Income(TTM)18.17M
Analysts81.82
Price Target30.35 (9.8%)
Short Float %8.55%
Short Ratio5.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.96%
Min EPS beat(2)27.09%
Max EPS beat(2)102.84%
EPS beat(4)3
Avg EPS beat(4)18.21%
Min EPS beat(4)-82.07%
Max EPS beat(4)102.84%
EPS beat(8)7
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)304.86%
EPS beat(16)11
Avg EPS beat(16)169.54%
Revenue beat(2)2
Avg Revenue beat(2)5.32%
Min Revenue beat(2)4.63%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)23.96%
PT rev (3m)76.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.92%
EPS NY rev (1m)0.25%
EPS NY rev (3m)29.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.9 | ||
| Fwd PE | 27.1 | ||
| P/S | 1.98 | ||
| P/FCF | 15.67 | ||
| P/OCF | 14.76 | ||
| P/B | 3.01 | ||
| P/tB | 4.61 | ||
| EV/EBITDA | 17.52 |
EPS(TTM)0.77
EY2.79%
EPS(NY)1.02
Fwd EY3.69%
FCF(TTM)1.76
FCFY6.38%
OCF(TTM)1.87
OCFY6.78%
SpS13.94
BVpS9.17
TBVpS5.99
PEG (NY)2.4
PEG (5Y)7.38
Graham Number12.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROCE | 10.46% | ||
| ROIC | 7.56% | ||
| ROICexc | 11.94% | ||
| ROICexgc | 24.41% | ||
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% | ||
| FCFM | 12.65% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 36.37% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 17.31 | ||
| Cash Conversion | 140.64% | ||
| Profit Quality | 216.85% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 | ||
| Altman-Z | 9.03 |
F-Score7
WACC9.81%
ROIC/WACC0.77
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y14.93%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
EBIT growth 1Y7.23%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year85.47%
EBIT Next 3Y35.54%
EBIT Next 5YN/A
FCF growth 1Y99.58%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y95.92%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
ChartMill assigns a valuation rating of 5 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for TCMD stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 35.9 and the Price/Book (PB) ratio is 3.01.
What is the expected EPS growth for TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Earnings per Share (EPS) of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is expected to grow by 14.93% in the next year.